Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
2,898
Funds Holding Change
+4
Funds Holding Growth
+0.1%
Value
$949B
Holding in Top 10
1,382
Top 10 Change
+99
Top 10 Growth
+8%
Value Growth
+7%
New
101
Increased
1,327
Reduced
1,302
Closed
69
Capital Inflow
$27.5B
Capital Outflow
$33.8B
Net Capital Flow
-$6.29B
Capital Flow Change
-$2.68B
Calls
$11.3B
Puts
$12.6B
Net Calls
-$1.24B
Put/Call Ratio
1.11